New insight into strategies used to develop long-acting G-CSF biologics for neutropenia therapy
Sign Up to like & getrecommendations! Published in 2023 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2022.1026377
Abstract: Over the last 20 years, granulocyte colony-stimulating factors (G-CSFs) have become the major therapeutic option for the treatment of patients with neutropenia. Most of the current G-CSFs require daily injections, which are inconvenient and expensive… read more here.
Keywords: csf; strategies used; insight strategies; long acting ... See more keywords